Celltrion to Seek New Drug, CDMO Partners at Milan Trade Show
MT Newswires Live
Sep 29
Celltrion (KRX:068270) will participate in a Milan trade convention in October to expand its network of global partners, according to a Tuesday statement.
Through the trade show, the company looks to gain partners in new drug development, supply chain diversification and cost competitiveness, as well as contract development and manufacturing organizations (CDMOs).
The 2026 Convention on Pharmaceutical Ingredients (CPHI) Worldwide will run from Oct. 6 to 8, with more than 60,000 participating industry experts from 2,400 companies and 170 countries.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.